If there’s any doubt that America’s teens have suffered mightily during the pandemic, a new government survey offers fresh proof of the pain restrictions from the coronavirus has inflicted on this vulnerable group. Many high schoolers have experienced physical and emotional abuse, poor mental health and chronic sadness and hopelessness as COVID-19 raged across the… read on > read on >
A little about: Weekly Sauce
All Sauce from Weekly Sauce:
New White House Website Speeds Access to Free COVID Care
The Biden administration announced Wednesday that it has launched a new website that includes help for people trying to find free COVID prevention and treatment quickly. COVID.gov will bring into one place several types of critical COVID-19 information, from finding high-quality masks to testing requirements for international travel. “We could not have done this six… read on > read on >
Bong Use at Home Quickly Fills Air With Toxins
Smoking pot through a bong doesn’t protect the nonsmokers in the room from the dangers of secondhand smoke, a new study warns. Bongs have been touted as a safe way to protect nonsmokers from secondhand marijuana smoke. But it can expose them to extremely high concentrations of fine particulate matter — five to 10 times… read on > read on >
AHA News: After COVID-19, Experts Say Watch For These Potential Heart and Brain Problems
THURSDAY, March 31, 2022 (American Heart Association News) — COVID-19 was full of surprises early on, causing mild problems in the short term for some people and serious complications for others. Long term, it may be just as capricious. Studies are spotting potential heart and brain problems up to a year after infection with SARS-CoV-2,… read on > read on >
New Drug May Ease Tourette Tics in Kids, Teens
An experimental drug shows promise in reducing tics in young people with Tourette syndrome. Ecopipam, which failed as a weight loss medication, may reduce tics by 30% in kids and teens with Tourette without the unpleasant side effects of current treatments, researchers say. “This drug significantly reduced tics, compared to placebo, and did not have… read on > read on >
FDA Advisory Panel Narrowly Votes Against New ALS Drug
In a close vote, an advisory panel for the U.S. Food and Drug Administration decided not to recommend the approval of an experimental drug for the deadly neurological disease amyotrophic lateral sclerosis (ALS). The panel’s decision had been closely watched, with patient advocacy groups lobbying hard for fast-track approval. However, on Wednesday the panel ruled… read on > read on >
New Way to Blast Kidney Stones Can Be Done in Doctor’s Office
A noninvasive ultrasound technique is capable of quickly pulverizing kidney stones, an early study shows — in what researchers call a first step toward a simpler, anesthesia-free treatment for the painful problem. The study reports on the first 19 patients who’ve had kidney stones treated with the ultrasound “bursts.” So far, it’s been able to… read on > read on >
Biden to Lift Pandemic Rule Restricting Immigrants at Land Border
(HealthDay News ) — An emergency health order that has curtailed immigration at U.S. land borders is expected to be lifted in late May. An announcement about rescinding the order — which has been in place since the start of the pandemic and is called Title 42 — is expected by the Biden administration this… read on > read on >
CDC Lifts Warning on Cruise Ship Travel
A two-year advisory that warned Americans against going on cruises has been dropped by the U.S. Centers for Disease Control and Prevention. The agency first warned Americans against cruise ship travel in 2020 at the height of the pandemic, and last year said there was an increased risk of getting infected when on the crowded… read on > read on >
Even During Omicron, Pfizer Vaccine Slashed Hospitalizations for Kids Aged 5 to 11
The Pfizer COVID vaccine significantly reduced U.S. children’s risk of severe illness and hospitalization during the recent Omicron surge, according to a new study. But researchers noted that only 27% of 5- to 11-year-olds in the United States and just 57% of 12- to 17-year-olds had received two vaccine doses as of March 16, and… read on > read on >